期刊文献+

阿仑磷酸钠、辛伐他汀对体外成骨细胞和破骨细胞的作用 被引量:6

Mechanisms of alendronate and simvastatin on the osteoblasts and osteoclasts cultured in vitro
下载PDF
导出
摘要 目的:观察阿仑磷酸钠联合辛伐他汀对体外成骨细胞、破骨细胞的影响,探讨2种药物联合应用治疗骨质疏松的可行性。方法:分离新生大鼠成骨细胞和破骨细胞,给予阿仑磷酸钠、辛伐他汀刺激,观察药物对成骨细胞增殖率、碱性磷酸酶活性及破骨细胞骨吸收的影响。结果:联合应用阿仑磷酸钠和辛伐他汀较单独用药更明显增强成骨细胞活性和抑制破骨细胞的骨吸收。结论:联合应用阿仑磷酸钠和辛伐他汀比单独应用阿仑磷酸钠可能对骨质疏松有更好的防治作用。 Objective:To observe the effects of alendronate combined with simvastatin on the osteoblasts and osteoclasts cultured in vitro. Methods:Osteoblasts and osteoclasts isolated from newborn rats were stimulated with alendronate and simvastatin. Proliferation ratio and alkaline phosphatase(ALP) activity of osteoblasts were assessed,and bone resorb activity of osteoclasts were detected. Results: Alendronate combined with simvastatin more effectively enhanced proliferation ratio and alkaline phosphatase (ALP)activity of osteoblasts and inhibited the bone resorb activity of osteoclasts compared with administration separately. Conclusion:Combined appli- cation of alendronate and simvastatin probably has better effects than simply application of alendronate on the osteoporosis.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第12期1690-1693,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅医学科技发展基金科研课题及补助基金资助(J200507)
关键词 阿仑磷酸钠 辛伐他汀 骨质疏松 alendronate simvastatin osteoporosis
  • 相关文献

参考文献12

  • 1Lupatteli G, Scarponi AM, Vaudo G, et al. Simvastatin increase bone mineral density in hypercholesterolemic post menopausal women [ J ]. Metabolism, 2004,53 (6) : 744-750.
  • 2Mundy G, Garrett R,Harris S,et al. Stimulation of bone formation in vitro and in rodents by statins[J]. Science, 1999,286(5446) : 1946-1949.
  • 3Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and miner alization in MC3T3-E1 cells [J]. Biochem Biophys Res Commun, 2001,280(3 ) : 874-877.
  • 4Ohnaka K,Shimoda S, Nawata H,et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts [J]. Biochem Biophys Res Commun, 2001,287(2) : 337-342.
  • 5Kaji H,Kanatani M,Sugimoto T,et al. Statins modulate the levels of osteoprotegerirr/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures [J].Horm Metab Res, 2005,37 (10) : 589-592.
  • 6Kaji H, Natio J, Inoue Y, et al. Statin suppresses apoptosis in osteoblastic cells:role of transforming growth factor-beta-smad3 pathway [ J ]. Horm Metab Res, 2008,40 ( 11 ) : 746-751.
  • 7Wang JW,Xu SW,Yang DS,et al. I-ocally applied simvastatin promotes fracture healing in ovariectomized rat [J]. Osteoporos Int,2007,18(12) : 1641-1650.
  • 8Maeda T,Matsunuma A,Kurahashi I,et al. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells[J]. J Cell Biochem,2004,92(3):458-471.
  • 9Woo JT,Kasai S,Stern PH,et al. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts[J]. J B one Miner Res, 2000,15 (4) : 650-662.
  • 10余利鹏,范卫民,张宁,罗永湘.阿托伐他汀对骨髓来源的成骨细胞中OPG mRNA/RANKL mRNA水平的影响[J].南京医科大学学报(自然科学版),2005,25(8):544-546. 被引量:2

二级参考文献5

  • 1G Mundy, R Harris, J Chen, et al. Stimulation of bone formation in vitro and in rodents by statins [J]. Science,1999, 286: 1946-1949.
  • 2Teitelbaum SL. Bone resorption by osteoclasts[J]. Science,2000, 289 (5484): 1504-1508.
  • 3Lorenz C Hofbauer. Osteoprotegerin ligand and steoprotegerin: novel implications for osteoclast biology and bone metabolism [J]. European Journal of Endocrinology, 1999, 141:195-210.
  • 4Lacey DL,Timms E,Tan HL, et al. Osteoprotegrin ligand is a cytokine that regulate osteoclast differentiation and activation[J]. Cell, 1998, 93:165-176.
  • 5Lorenz C Hofbauer. The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption[J]. J Bone Miner Res, 2000, 15: 2-12.

共引文献1

同被引文献65

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部